OMX Nordic 40 2729754 / SE0001809476
2’437.72
Pkt
25.37
Pkt
1.05
%
17:35:08
Anzeige
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Marktkapitalisierung | |||||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu OMX Nordic 40-Werten
| 20.11.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.11.24 | AstraZeneca Neutral | UBS AG | |
| 19.11.24 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 19.11.24 | Volvo AB Neutral | UBS AG | |
| 18.11.24 | Novo Nordisk Neutral | UBS AG | |
| 15.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 14.11.24 | Volvo AB Neutral | JP Morgan Chase & Co. | |
| 14.11.24 | A.P. Moeller - Maersk A-S Neutral | Goldman Sachs Group Inc. | |
| 13.11.24 | AstraZeneca Halten | DZ BANK | |
| 13.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 13.11.24 | Novo Nordisk Neutral | UBS AG | |
| 13.11.24 | Hennes & Mauritz AB Buy | UBS AG | |
| 13.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 12.11.24 | AstraZeneca Sell | UBS AG | |
| 12.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 12.11.24 | ABB Neutral | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.11.24 | Novo Nordisk Neutral | UBS AG | |
| 11.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 11.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | Novo Nordisk Overweight | Barclays Capital | |
| 07.11.24 | Novo Nordisk Neutral | UBS AG | |
| 07.11.24 | Novo Nordisk Halten | DZ BANK | |
| 07.11.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 06.11.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | Novo Nordisk Neutral | UBS AG | |
| 06.11.24 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | Hennes & Mauritz AB Outperform | RBC Capital Markets |